Bayer asks judge in second glyphosate-cancer case to restrict evidence to be presented against Monsanto

| | January 23, 2019

Bayer AG unit Monsanto has asked a California judge in the litigation over its glyphosate-based weed killer Roundup allegedly causing cancer to limit evidence by splitting an upcoming trial into two phases, a request previously successful with another judge.

Monsanto in a previously unreported filing on Jan. 15 asked California Superior Court Judge Winifred Smith in Oakland to split a March trial by a California couple into two phases.

Such a step would limit evidence the plaintiffs in the litigation consider crucial to their cases and describe as critical to a jury last year awarding $289 million in a similar case.

Under the company’s proposal, lawyers for Alva and Alberta Pilliod in the initial trial phase would be barred from introducing evidence that the company allegedly attempted to influence regulators and manipulate public opinion.

Related article:  Hazard vs risk: California's Prop 65 relies on 'flawed approach' of WHO's IARC cancer agency

Such evidence would be allowed only if glyphosate was found to have caused the Pilliods’ cancer and the trial proceeded to a second phase to determine the company’s liability.

U.S. District Judge Vince Chhabria in San Francisco, who oversees the federal Roundup litigation with some 680 cases pending before him, on Jan. 3 approved the company’s request to initially limit evidence in upcoming trials before him.

Read full, original article: BAYER ASKS CALIFORNIA JUDGE TO LIMIT EVIDENCE IN ANOTHER ROUNDUP CANCER TRIAL

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend